Uncovering quality in China through bottom-up stock picking
Over the last twelve months, our Asia and Global Emerging Markets portfolios have been increasing their exposure to Chinese equities. As bottom-up stockpickers, we have become more optimistic about the potential returns from owning what we believe to be some of China’s best businesses at very reasonable valuations.
We are not new to investing in China. Our team has been visiting and researching companies in China for decades, and our portfolios have held Chinese equities as long as they have been running. Companies like Hong Kong & China Gas and Mindray Medical were core holdings for many years.
However, we have also been cognisant that China can be a risky place to invest, in part because of the way in which politics can intervene to upend business models. We are completely benchmark agnostic; we apply the same rigorous process to every potential investee company and seek the best investment ideas without recourse to index weightings. For much of the last decade, we have had lower exposure to Chinese equities than the relevant benchmarks.
New ideas and attractive valuations
The increase in the number of Chinese companies held in our Asia and Global Emerging Markets portfolios is a consequence of two changes.
Firstly, the Chinese market has got much deeper over time. The A-share markets in Shanghai and Shenzhen now contain over 5,000 listed companies and are being added to all the time through a robust pipeline of initial public offerings (IPOs) of new companies.
For the last few years, Shanghai and Shenzhen have been the number 1 and number 2 markets for new IPOs, and between them have raised 40% of all proceeds globally, twice as much as the United States.1
We have seen a steady increase in the number of high quality, privately-run companies in the healthcare, technology and industrial sectors. Investigating, watching and building up conviction in these A-share listed companies has been a strong research focus for quite some time and has allowed us to gradually generate a number of new ideas.
One example is Glodon. The Beijing-based company produces software used in the construction industry in China, to help operators to remove waste, cut costs, improve safety and save time. Its founder-operator management team have built a business with very high market shares, which stands to gain as labour shortages means digitalisation will be needed to improve productivity in sectors like construction. It is exactly the kind of exciting, earlier stage company we see more and more of in Shenzhen and Shanghai.
This brings us to the second reason that we now have increased exposure to Chinese companies. That is that valuations have become very attractive, even for high quality companies.
It seems as though the attitudes of foreign investors towards China oscillate between two extremes: either China should be at the core of everyone’s asset allocation, or else is uninvestable.
During times of optimism, including much of the recent past, the best Chinese companies – those privately-owned, competitively advantaged businesses with solid growth prospects have often been expensively valued. Consequently, whilst we had got to the point of high conviction in a range of Chinese companies over the last few years, we have been sat on the sidelines in a number of them due to prohibitive valuations.
However, it seems we are now closer to ubiquitous revulsion, with sentiment towards China extremely negative. This near-universal aversion to Chinese assets on behalf of foreign investors has presented opportunities to long-term investors willing to look past China’s short-term economic difficulties to buy equity in some of the country’s best businesses at very reasonable valuations.
One of example is Yifeng Pharmacy Chain, the country’s largest drug distributor. Pharmacies are a business we know well, and tend over time towards consolidation around a few large players. The Chinese market is in a very early stage of evolution, and as the leading consolidator of a vast market, Yifeng’s earnings are growing at around 20% per year. Yet its shares now trade around 8x price-to-cash flow (P/CF), and we have had the opportunity to build up positions across portfolios.2
By any measure, we believe these are great businesses at very attractive entry points for the long-term owner.
Risk factors
Capital at risk. The value of investments and any income from them may go down as well as up and are not guaranteed. Investors may get back significantly less than the original amount invested.
How to invest
There are different ways to buy shares in an investment trust.
Mitigating risks
China certainly remains a risky place to invest, given that policy changes are hard to predict and can have severe impacts. We believe this risk can be mitigated through both stock selection and portfolio construction.
Our starting point of seeking companies well-positioned to deliver sustainable development sets us off on the right foot; we are unlikely to own businesses that are, for instance, heavily polluting the environment, or causing public health problems, and thus obvious targets for government intervention.
We have always invested with the view that companies contributing solutions towards positive sustainable development are more likely to be able to grow more quickly, and with lower risk, and that is certainly true in China.
A good final example would be Centre Testing International, which is China’s leading provider of certification, testing and inspection services, guaranteeing compliance with quality standards and environmental regulations. The business will be driven by the inevitably greater focus placed on quality and safety in China over time, and in that sense is very well aligned with long-term sustainable development and Beijing’s goals. Centre Testing generates attractive returns and now trades on just 13x P/CF, and we have been adding throughout the last year.3
The cases described above are typical of the types of businesses we are most excited about in China. Common features include:
- run by credible former executives of multi-nationals, whose former employers give us some reference points in terms of their competence and integrity.
- partnerships with multi-national firms, evidencing technical capabilities as well as a willingness to deal fairly with foreign stakeholders.
- business models which have been proven to have fantastic economics in more mature markets.
- relatively niche businesses, hopefully below the radar of regulators.
- products and services that contribute positively to China’s continued development, and so should be aligned with Beijing.
- Business-to-business (B2B) franchises, which seems likely to be less politically sensitive and thus less vulnerable to policy intervention.
We believe these types of companies are likely to be lower risk than many others in China.
Nonetheless, cognisant that in any given case, we may be wrong, we have been adding increasing our exposure to these companies modestly and gradually. At the margin, we have been lengthening the number of companies in some portfolios in order to accommodate the current situation.
Every company that we own in China (and elsewhere) can be viewed on our Portfolio Explorer tool. We update the holdings on a quarterly basis.
As long-term investors, periods of economic turbulence and the associated market sell-offs can give us fantastic opportunities to buy quality companies for our clients. In that context, investing in a very select group of competitively advantaged, hopefully lower risk companies in China seems prudent. We believe these companies can deliver attractive returns to clients over the long term.
Risk factors
This web page is a financial promotion for Pacific Assets Trust plc (the “Trust”) only for those people resident in the UK and Ireland for tax and investment purposes.
Investing involves certain risks including:
- The value of investments and any income from them may go down as well as up and are not guaranteed. Investors may get back significantly less than the original amount invested.
- Emerging market risk: emerging markets tend to be more sensitive to economic and political conditions than developed markets. Other factors include greater liquidity risk, restrictions on investment or transfer of assets, failed/delayed settlement and difficulties valuing securities.
- Specific region risk: investing in a specific region may be riskier than investing in a number of different countries or regions. Investing in a larger number of countries or regions helps spread risk.
- Currency risk: the Trust invests in assets which are denominated in other currencies; changes in exchange rates will affect the value of the Trust and could create losses. Currency control decisions made by governments could affect the value of the Trust’s investments.
- The Trust’s share price may not fully reflect net asset value.
Where featured, specific securities or companies are intended as an illustration of investment strategy only, and should not be construed as investment advice or a recommendation to buy or sell any security.
For an overview of the terms of investment, risks, returns, costs and charges please refer to the Key Information Document.
If you are in any doubt as to the suitability of the Trust for your investment needs, please seek investment advice.
Important information
This material is for general information purposes only. It does not constitute investment or financial advice and does not take into account any specific investment objectives, financial situation or needs. This is not an offer to provide asset management services, is not a recommendation or an offer or solicitation to buy, hold or sell any security or to execute any agreement for portfolio management or investment advisory services and this material has not been prepared in connection with any such offer. Before making any investment decision you should conduct your own due diligence and consider your individual investment needs, objectives and financial situation and read the relevant offering documents for details including the risk factors disclosure.
Any person who acts upon, or changes their investment position in reliance on, the information contained in these materials does so entirely at their own risk.
We have taken reasonable care to ensure that this material is accurate, current, and complete and fit for its intended purpose and audience as at the date of publication. No assurance is given or liability accepted regarding the accuracy, validity or completeness of this material.
To the extent this material contains any expression of opinion or forward-looking statements, such opinions and statements are based on assumptions, matters and sources believed to be true and reliable at the time of publication only. This material reflects the views of the individual writers only. Those views may change, may not prove to be valid and may not reflect the views of everyone at First Sentier Investors.
Past performance is not indicative of future performance. All investment involves risks and the value of investments and the income from them may go down as well as up and you may not get back your original investment. Actual outcomes or results may differ materially from those discussed. Readers must not place undue reliance on forward-looking statements as there is no certainty that conditions current at the time of publication will continue.
References to specific securities (if any) are included for the purpose of illustration only and should not be construed as a recommendation to buy or sell the same. Any securities referenced may or may not form part of the holdings of First Sentier Investors' portfolios at a certain point in time, and the holdings may change over time.
References to comparative benchmarks or indices (if any) are for illustrative and comparison purposes only, may not be available for direct investment, are unmanaged, assume reinvestment of income, and have limitations when used for comparison or other purposes because they may have volatility, credit, or other material characteristics (such as number and types of securities) that are different from the funds managed by First Sentier Investors.
Selling restrictions
Not all First Sentier Investors products are available in all jurisdictions.
This material is neither directed at nor intended to be accessed by persons resident in, or citizens of any country, or types or categories of individual where to allow such access would be unlawful or where it would require any registration, filing, application for any licence or approval or other steps to be taken by First Sentier Investors in order to comply with local laws or regulatory requirements in such country.
This material is intended for ‘professional clients’ (as defined by the UK Financial Conduct Authority, or under MiFID II), ‘wholesale clients’ (as defined under the Corporations Act 2001 (Cth) or Financial Markets Conduct Act 2013 (New Zealand) and ‘professional’ and ‘institutional’ investors as may be defined in the jurisdiction in which the material is received, including Hong Kong, Singapore, Japan, and the United States, and should not be relied upon by or be passed to other persons.
The First Sentier Investors funds referenced in these materials are not registered for sale in the United States and this document is not an offer for sale of funds to US persons (as such term is used in Regulation S promulgated under the 1933 Act). Fund-specific information has been provided to illustrate First Sentier Investors’ expertise in the strategy. Differences between fund-specific constraints or fees and those of a similarly managed mandate would affect performance results.
About First Sentier Investors
References to ‘we’, ‘us’ or ‘our’ are references to First Sentier Investors, a global asset management business which is ultimately owned by Mitsubishi UFJ Financial Group (MUFG). Certain of our investment teams operate under the trading names AlbaCore Capital Group, FSSA Investment Managers, Stewart Investors and RQI Investors all of which are part of the First Sentier Investors group.
This material may not be copied or reproduced in whole or in part, and in any form or by any means circulated without the prior written consent of First Sentier Investors.
We communicate and conduct business through different legal entities in different locations. This material is communicated in:
- Australia and New Zealand by First Sentier Investors (Australia) IM Ltd, authorised and regulated in Australia by the Australian Securities and Investments Commission (AFSL 289017; ABN 89 114 194311)
- European Economic Area by First Sentier Investors (Ireland) Limited, authorised and regulated in
- Ireland by the Central Bank of Ireland (CBI reg no. C182306; reg office 70 Sir John Rogerson’s Quay, Dublin 2, Ireland; reg company no. 629188)
- Hong Kong by First Sentier Investors (Hong Kong) Limited and has not been reviewed by the Securities & Futures Commission in Hong Kong. First Sentier Investors, FSSA Investment Managers, Stewart Investors, RQI Investors and Igneo Infrastructure Partners are the business names of First Sentier Investors (Hong Kong) Limited.
- Singapore by First Sentier Investors (Singapore) (reg company no. 196900420D) and this advertisement or material has not been reviewed by the Monetary Authority of Singapore. First Sentier Investors (registration number 53236800B), FSSA Investment Managers (registration number 53314080C), Stewart Investors (registration number 53310114W), RQI Investors (registration number 53472532E) and Igneo Infrastructure Partners (registration number 53447928J) are the business divisions of First Sentier Investors (Singapore).
- United Kingdom by First Sentier Investors (UK) Funds Limited, authorised and regulated by the Financial Conduct Authority (reg. no. 2294743; reg office Finsbury Circus House, 15 Finsbury Circus, London EC2M 7EB)
- United States by First Sentier Investors (US) LLC, authorised and regulated by the Securities Exchange Commission (RIA 801-93167).
- other jurisdictions, where this document may lawfully be issued, by First Sentier Investors International IM Limited, authorised and regulated in the UK by the Financial Conduct Authority (FCA ref no. 122512; Registered office: 23 St. Andrew Square, Edinburgh, EH2 1BB; Company no. SC079063).
To the extent permitted by law, MUFG and its subsidiaries are not liable for any loss or damage as a result of reliance on any statement or information contained in this document. Neither MUFG nor any of its subsidiaries guarantee the performance of any investment products referred to in this document or the repayment of capital. Any investments referred to are not deposits or other liabilities of MUFG or its subsidiaries, and are subject to investment risk, including loss of income and capital invested.
© First Sentier Investors Group
